Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Find out if there is evidence for this, plus safety and side effects
Enhertu (Trastuzumab deruxtecan) from Daiichi Sankyo and AstraZeneca has quarterly sales over $1 billion and is projected to reach $5 billion in 2025
Vial and syringe injections, common with compounded formulations , require more technique but offer greater flexibility
For veterans on fixed incomes or those without VA coverage approval, this price difference creates real access to therapy that might otherwise remain unaffordable
Jiao et al., 2021)
Injecting through wet alcohol introduces contamination
US$ 20.19
US$ 21.63
US$ 28.46
US$ 23.05
US$ 26.69
